Evidence map›Paper›PMID 37048645›Full record

ArticleJournal of clinical medicine2023

The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma.

Natalie K Heater, Scott Okuno, Steven Robinson, Steven Attia, Mahesh Seetharam, Brittany L Siontis, Janet Yoon, Sant Chawla, Mohammed M Milhem, Varun Monga and 6 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Natalie K HeaterDepartment of Medicine, Northwestern University, Chicago, IL 60611, USA.
Scott OkunoDepartment of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA.
Steven RobinsonDepartment of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA.
Steven AttiaDepartment of Hematology and Oncology, Mayo Clinic, Jacksonville, FL 32224, USA.
Mahesh SeetharamDepartment of Hematology and Oncology, Mayo Clinic, Phoenix, AZ 85054, USA.
Brittany L SiontisDepartment of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA.
Janet YoonCity of Hope Medical Center, Duarte, CA 91010, USA.
Sant ChawlaSarcoma Oncology Center, Santa Monica, CA 90403, USA.
Mohammed M MilhemDepartment of Internal Medicine, Division of Hematology, Oncology and Blood and Marrow Transplantation, University of Iowa, Iowa City, IA 52242, USA.
Varun MongaDepartment of Internal Medicine, Division of Hematology, Oncology and Blood and Marrow Transplantation, University of Iowa, Iowa City, IA 52242, USA.ORCID 0000-0002-1185-5448
Keith SkubitzMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.ORCID 0000-0002-0690-9595
John CharlsonDepartment of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Angela C HirbeDivision of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63130, USA.ORCID 0000-0003-1719-0771
Mia C WeissDivision of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63130, USA.
Brian Van TineDivision of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63130, USA.ORCID 0000-0003-4572-6668
Mark AgulnikCity of Hope Medical Center, Duarte, CA 91010, USA.ORCID 0000-0003-3513-3519

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Christopher K Laubenthal · 2000 to 2026
$70.0M
NCI NIH HHS P30 CA086862
6 · The paper itself

Abstract

The treatment of sarcoma necessitates a collaborative approach, given its rarity and complex management. At a single institution, multidisciplinary teams of specialists determine and execute treatment plans involving surgical, radiation, and medical management. Treatment guidelines for systemic therapies in advanced or nonresectable soft tissue sarcoma have advanced in recent years as new immunotherapies and targeted therapies become available. Collaboration between institutions is necessary to facilitate accrual to clinical trials. Here, we describe the success of the Midwest Sarcoma Trials Partnership (MWSTP) in creating a network encompassing large academic centers and local community sites. We propose a new model utilizing online platforms to expand the reach of clinical expertise for the treatment of advanced soft tissue sarcoma.

Indexed as

advanced soft tissue sarcomacollaborationMidwest Sarcoma Trials Partnershipmultidisciplinary tumor boardsarcoma treatmenttargeted therapy

Identifiers

PMID37048645
PMCPMC10095464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.